Melox

Meloxicam, the active ingredient in Melox, is a nonsteroidal anti‑inflammatory drug (NSAID) presented as an injectable solution for intramuscular use. It provides anti‑inflammatory, analgesic and antipyretic effects and is indicated for managing osteoarthritis, rheumatoid arthritis, acute musculoskeletal pain and post‑operative pain in adult patients.

GNH USA supplies Melox as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality and regulatory compliance across global markets. The company adheres to EU Good Manufacturing Practice and provides reliable logistics for temperature‑controlled products where required.

Meloxicam is an NSAID that reduces inflammation and pain in musculoskeletal disorders. - Osteoarthritis: reduces joint inflammation and pain, improving mobility. - Rheumatoid arthritis: alleviates inflammatory joint damage and discomfort. - Acute musculoskeletal pain: provides rapid analgesia for injuries or strains. - Post‑operative pain: helps control pain following surgical procedures.

Meloxicam may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Gastrointestinal discomfort: nausea, dyspepsia or abdominal pain. - Headache: mild to moderate intensity. - Dizziness or vertigo: transient sensations of light‑headedness. - Injection site reactions: erythema, swelling or pain at the intramuscular site. - Elevated liver enzymes: mild, reversible increases in hepatic transaminases.

Serious or Rare Side Effects: - Severe gastrointestinal ulceration or bleeding. - Cardiovascular events: myocardial infarction or stroke. - Renal impairment: acute kidney injury or worsening of chronic kidney disease. - Hypersensitivity reactions: rash, angioedema or anaphylaxis. - Hepatotoxicity: significant liver injury with jaundice.

When prescribing meloxicam, clinicians should consider several safety precautions to minimize risk. - Assess renal function: avoid use in patients with severe renal impairment. - Monitor hepatic enzymes: use caution in those with liver disease. - Evaluate cardiovascular risk: limit use in patients with history of heart disease or stroke. - Avoid concurrent NSAIDs or anticoagulants: increased bleeding risk. - Pregnancy and lactation: use only if benefits outweigh potential risks. - Store at ambient temperature: keep below 25 °C, protect from moisture and light in original packaging.

Meloxicam can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of serious bleeding. - Other NSAIDs or COX‑2 inhibitors: additive gastrointestinal toxicity. - ACE inhibitors or ARBs: may reduce renal function when combined.

Moderate Interactions (Monitor Closely): - Diuretics: potential for reduced antihypertensive effect and renal impairment. - Lithium: increased lithium levels, risk of toxicity. - Methotrexate: decreased clearance leading to heightened toxicity. - SSRIs or SNRIs: heightened bleeding tendency.